| 6MWT | 6-Minute Walk Test |
| AAV | Adeno-associated virus |
| ACTB | Actin beta |
| AD | Alzheimer’s disease |
| ADM | Abductor digiti minimi |
| Aldh4a1 | Aldehyde dehydrogenase 4 family, member A1 |
| ADMA | Asymmetric dimethylarginine |
| ALS | Amyotrophic lateral sclerosis |
| ALSFRS-R | Amyotrophic Lateral Sclerosis Functional Rating Scale—Revised |
| APP | Amyloid precursor protein |
| ASC-EVs | Exosomes derived from adipose-derived stem cells |
| ASOs | Antisense oligonucleotides |
| Aβ | Amyloid-β |
| BACE1 | β-site APP cleaving enzyme-1 |
| BBB | Blood–brain barrier |
| Bcl2 | B-cell lymphoma 2 |
| BI | Barthe index |
| BMI | Body mass index |
| Bmp4 | Barthel Index |
| CCL5 | C-C motif chemokine ligand 5 |
| CCR | Creatinine-to-cystatin C ratio |
| ceRNA | Competing endogenous RNA |
| CHD4 | Chromodomain helicase DNA binding protein 4 |
| CHI3L1 | Chitinase-3-like protein 1 |
| CHIT1 | Chitotriosidase 1 |
| Chl1 | Cell adhesion molecule L1-like protein |
| CHOP INTEND | Children’s Hospital of Philadelphia Infant test of Neuromuscular Disorders |
| CK | Creatine kinase |
| CMAP | Compound muscle action potential |
| CNS | Central nervous system |
| Cplx2 | Complexin 2 |
| Crn | Creatinine |
| CSF | Cerebrospinal fluid |
| DYNC1H1 | Dynein cytoplasmic 1 heavy chain 1 |
| EI | Muscle echogenicity |
| EIM | Electrical impedance myography |
| ELISA | Enzyme-linked immunosorbent assay |
| EMG | Electromyographic |
| Gata6 | GATA binding protein 6 |
| GDF15 | Growth differentiation factor 15 |
| GFAP | Glial fibrillary acidic protein |
| GSEA | Gene set enrichment analysis |
| HDL | High-density lipoprotein |
| HFMSE | Hammersmith functional motor scale–expanded |
| HINE-2 | Section 2 of the Hammersmith Infant Neurological Examination |
| HNRNPA1 | Heterogeneous nuclear ribonucleoprotein A1 |
| HSPA7 | Heat shock protein family A member 7 |
| IBA1 | Ionized calcium binding adaptor molecule 1 |
| IL | Interleukin |
| IL-1ra | Interleukin-1 receptor antagonist |
| INF-γ | Interferon-γ |
| ISL1 | ISL LIM homeobox 1 |
| JUND | JunD Proto-Oncogene |
| LDA | Linear discriminant analysis |
| Lif | Leukemia inhibitory factor |
| MCP-1 | Monocyte chemoattractant protein-1 |
| MFM | Motor Function Measurement |
| MIP-1β | Macrophage inflammatory protein-1β |
| miRNAs | MicroRNAs |
| MMA/SDMA | Monomethylarginine/symmetric dimethylarginine |
| MOST | Multispectral optoacoustic tomography |
| MT | Muscle thickness |
| MUNE | Motor unit number estimation |
| MUNIX | Motor unit number index |
| myomiRs | Muscle-specific miRNAs |
| NCOR2 | Nuclear receptor corepressor 2 |
| NCX2 | Sodium-calcium exchanger 2 |
| NfH | Neurofilament heavy chain |
| NfL | Neurofilament light chain |
| NfM | Neurofilament medium chain |
| NFs | Neurofilaments |
| NF-κB | Nuclear factor kappa B |
| NPV | Negative predictive value |
| Pak4 | P21-activated kinase 4 |
| PCR | Polymerase chain reaction. |
| PLS3 | Plastin 3 |
| PME | Progressive myoclonic epilepsy |
| pNfH | Phosphorylated neurofilament heavy chain |
| PRMT | Protein arginine methyltransferase |
| Ptgs2 | Prostaglandin-endoperoxide synthase 2 |
| QAlb | Albumin quotient |
| RHOA | Ras homolog family member A |
| ROCK1 | Rho-associated coiled-coil containing protein kinase 1 |
| RULM | Revised upperlimb module |
| S100B | S100 calcium-binding protein B |
| sAPP | Soluble amyloid precursor protein |
| SD | Standard deviation |
| SIMOA | Sensitive single-molecule array |
| SLC23A2 | Solute carrier family 23 member 2 |
| SMA | Spinal muscular atrophy |
| SMA-PME | SMA with progressive myoclonic epilepsy |
| SMN | Survival motor neuron |
| snRNP | Small nuclear ribonucleoprotein |
| Syt | Synaptotagmin |
| SOX2 | SRY-box transcription factor 2 |
| TBXT | T-box transcription factor T |
| TNF-α | Tumor necrosis factor-alpha |
| TRADD | TNF Receptor-Associated Death Domain |
| WGCNA | Weighted correlation network analysis |